Expression of Tac antigen by non-Hodgkin's lymphomas
Abstract
Anti-Tac is a monoclonal antibody that appears to recognize the interleukin-2 receptor. With the use of a frozen-section immunoperoxidase technic, a large series of non-Hodgkin's lymphomas were investigated for the presence of Tac-antigen on neoplastic cells. Approximately one-fourth of cases expressed the Tac antigen, including 27% of B-lineage lymphomas, 6% of the T-lineage lymphomas, and three of four cases of Ki-1-expressing lymphoma. The B-lineage lymphomas with the highest incidence of Tac antigen expression were the large cell lymphomas, both diffuse and follicular, where about one-half of cases expressed the Tac antigen. All major categories of lymphoma expressed Tac except plasmacytoma/myeloma, small noncleaved cell (Burkitt's and non-Burkitt's), and lymphoblastic malignancies.
Publication Title
American Journal of Clinical Pathology
Recommended Citation
Weiss, L., Michie, S., Medeiros, L., Strickler, J., Garcia, C., & Warnke, R. (1987). Expression of Tac antigen by non-Hodgkin's lymphomas. American Journal of Clinical Pathology, 88 (4), 483-485. https://doi.org/10.1093/ajcp/88.4.483